VRTX vs AAPL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AAPL has stronger fundamentals based on our AI analysis.

VRTX
VERTEX PHARMACEUTICALS INC / MA
BUY
86%
Confidence
VS
AAPL
Apple Inc.
BUY
87%
Confidence

VRTX vs AAPL Fundamental Comparison

Metric VRTX AAPL
Revenue $12.0B $143.8B
Net Income $4.0B $42.1B
Net Margin 32.9% 29.3%
ROE 21.2% 47.7%
ROA 15.4% 11.1%
Current Ratio 2.90x 0.97x
Debt/Equity 0.01x 1.00x
EPS $15.32 $2.84

Green = Better metric | Red = Weaker metric

View Full VRTX Analysis →
View Full AAPL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

VRTX vs MSFT AAPL vs GOOGL VRTX vs AMZN AAPL vs NVDA

VRTX vs AAPL: Frequently Asked Questions

Is VRTX or AAPL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. VRTX is rated BUY (86% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.

How does VRTX compare to AAPL fundamentally?

VERTEX PHARMACEUTICALS INC / MA has ROE of 21.2% vs Apple Inc.'s 47.7%. Net margins are 32.9% vs 29.3% respectively.

Which stock pays higher dividends, VRTX or AAPL?

VRTX has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in VRTX or AAPL for long term?

For long-term investing, consider that VRTX has BUY rating with 86% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about VRTX vs AAPL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For VRTX vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.